1.Use of Intestinal Microbiota Modulation for Treatment of Digestive System Diseases
Chinese Journal of Gastroenterology 2014;(11):692-694
ItisacknowIedgedthatintestinaImicrobiotapIaysanimportantroIeinIifeprocess.IntestinaIdysbiosisis invoIved in the pathogenesis of many diseases reIated to aImost every system of the body. Probiotics and fecaI microbiota transpIantation,which can moduIate intestinaI microbiota without severe adverse effects,has become a hot topic for disease treatment. This articIe summarized the use of intestinaI microbiota moduIation for treatment of digestive system diseases.
2.Progress of treatment of extranodal natural killer/T cell lymphoma
Xiaotong LI ; Lei FAN ; Jianyong LI
Journal of Leukemia & Lymphoma 2016;25(12):717-719
Extranodal natural killer/T cell lymphoma (ENKTL) is an EBV-associated and highly aggressive subtype of non-Hodgkin lymphoma. Most patients are distributed in Asia and South America, and advanced-stage patients have poor prognosis. Reports on research progress of ENKTL in the 58th American Society of Hematology Annual Meeting covered multiple respects which range from basic research to clinical prognosis and treatment: further study on pathogenesis of ENKTL is developing based on high-throughput sequence, and new prognostic index system can help to stratify patients more exactly; what's more, novel regimens make more benefits to the clinical efficacy and safety of ENKTL patients.
3.Treatment progress of chronic lymphocytic leukemia: reports from the 57th American Society of Hematology annual meeting
Yue LI ; Wei XU ; Jianyong LI
Journal of Leukemia & Lymphoma 2016;25(1):29-32
Chronic lymphocytic leukemia (CLL) is a chronic B-cell lymphoproliferative clonal disease with a highly heterogeneous clinical course. In recent years, with the emerging of immunochemotherapy, bcl-2 inhibitor, B-cell receptor signal transduction kinase inhibitors and the chimeric antigen receptor-T cell (CAR-T), more and more improvements were made in CLL therapy and remission. This report addressed the progress of CLL therapy in the 57th American Society of Hematology annual meeting.
4.Histone deacetylase inhibitors in treatment of hematological malignancies
Ke SHI ; Yi MIAO ; Jianyong LI
Journal of Leukemia & Lymphoma 2016;25(12):705-708
Histone deacetylase inhibitor (HDACi) is a novel antineoplastic agent emerging in recent years. The advent of HDACi has provided new options for the treatment of malignant tumors, parasitic and inflammatory diseases. HDACi, as single agent or in combination with other drugs, has a considerable prospect in the treatment of hematological malignancies. The use of HDACi in the treatment of hematological malignancies will be summarized in this paper based on the reports in the 58th ASH Annual Meeting.
5.Treatment of primary liver cancer by liver cancer vaccine activated TIL
Ting LI ; Jianyong LIU ; Jianlun LIU
Chinese Journal of General Surgery 1997;0(04):-
ObjectiveTo study the effects of liver cancer vaccine activated TIL on primary liver cancer (PLC).Methods Twenty-six patients with PLC were treated with stimulated TIL by liver cancer vaccine. The CD3?CD4?CD8?CD4/CD8, NK activity and levels of serum sIL-2R were assayed before and after the treatment, the survival tates of 1, 2 and 3 year were analysed. ResultsCD3?CD4?CD4/CD8 and the activity of NKC were 55?3?76?5;28.3?1.6?44.6?2.3;1.19?0.22?2.21?0.36;9.8?1.2?17.4?2.2, at 19th and 30th day, respectively after treatment of TIL. The difference was all significant compared with the controls (P
6.A study on cancer vaccines made up of cells treated by TNF-? gene modifying combined with freezing
Jianyong LIU ; Litu ZHANG ; Ting LI
Chinese Journal of Immunology 2001;0(07):-
Objective:To investigate the possibility of producing vaccine with higher effect of anti-hepatoma by means of freezing the tumour cells which have been modified by TNF-? genes before. Methods: H22 cells which had been modified by TNF-? genes were treated by means of freezing and 60Co radiation or of 60Co radiation, respectively. Then, they were put to use to produce two kinds of vaccines. Effects of these two kinds of vaccines on anti- plant-hepatoma in mice were compared. Results: Effects of increasing the inhibiting rates, the levels of lectin-induced IL-2 and TNF from splenocytes, and the splentic NK activity, were all obviously seen stronger in vaccine made up of cells treated by the method combined with freezing, than that in vaccine made up of cells by no freezing. Conclusion: Method of freezing, after procedure of TNF-a gene modifying, could raise up the immunogenicity of the tumour cells, thereby enhance the anti-plant-hepatoma effect in mice induced by the vaccine.
7.Clinical study of color Doppler sonography in Graves' disease blood flow changes after thyroid arteries embolizaion.
Wenquan ZHUANG ; Weiduo LI ; Jianyong YANG
Journal of Interventional Radiology 1994;0(02):-
Objective To study the color doppler image characteristics of thyroid arteries pre and post interventional procedure and to assess the clinical efficacy in Gnaves' disease.Methods 11 from 31 patients diagnosed as Graves' disease undertaken thyroid arteries embolization, were analyzed. Color Doppler sonography was applied to monitor the pre and post procedure thyroid size and diameters of thyroid arteries. Power Doppler was used to detect the Vmax, Vmin, RI and blood flow. Results After thyroid arteries embolization, the size and vascularity of thyroids were reduced. The thyroid arteries showed shrinkage and stoppage blood flow at the embolized site. The changes of RI, blood parameters of Vmax, Vmin and diameters of the thyroid arteries pre and post procedure turned out to be statistically significant for clinical restriction.Conclusion The color Doppler sonography plays an important role for preoperative diagnosis and predicting the prognosis.
8.Efficacy and safety of tirofiban in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Yuqing HOU ; Zhongjiang ZHOU ; Jianyong LI
Chinese Journal of Interventional Cardiology 1996;0(01):-
Objective To investigate the efficacy and safety of tirofiban in acute coronary syndrome(ACS)patients during primary PCI.Methods Sixty two patients with ACS who underwent primary PCI were randomly divided into two groups which were:the tirofiban + PCI group(n=32)and the primary PCI group(n=30).Tirofiban was predominantly initiated in the catheter laboratory before or during the intervention and maintained for a mean of 30 h(10 ?g/kg for bolus,followed by 0.15 ?g/kg?min infusion).Platelet counting,MACE event and periprocedural complication were investigated.Heart function by echo was observed.Results The incidence of the major primary end point(refractory ischemia,new myocardial infarction and death)at 30 days was significantly lower in the tirofiban group than that in the placebo group(9.3% vs 20.0%,P
9.OVEREXPRESSION OF p27~(KIP1) INHIBITS GROWTH OF SGC7901 CELLS
Jianyong ZHENG ; Weizhong WANG ; Kaizong LI
Medical Journal of Chinese People's Liberation Army 2001;0(11):-
To elucidate the effect of p27 KIP1 on cell cycle and proliferation of gastric carcinoma cells, we transfected the full e length cDNA of p27 KIP1 into human SGC7910 gastric cancer cells by the method of lipofectin transfection. Expression of p27 KIP1 at protein or mRNA level was analyzed by Western blotting, and RNA dot blotting, respectively. Effect of p27 KIP1 on cell growth was observed by trpan blue exclusion assay and anchorage independent growth in soft agar. Flow cytometry was applied to assess the effect of p27 KIP1 on cell cycle. The results showed that the expression of p27 KIP1 at protein or mRNA level increased evidently in SGC7901 cells transfected with p27 KIP1 . The cell growth was reduced by 42% 48h post induction with zinc as determined by cell viability assay. The rate of anchorage independent growth in soft agar decreased significantly. p27 KIP1 over expression caused cell arrest at G 1 by 36%(from 33 68% to 69 29%, P
10.CONSTRUCTION OF AN INDUCIBLE VECTOR CARRYING GREEN FLUORESCENT PROTEIN
Jianyong ZHENG ; Kaizong LI ; Weizhong WANG
Medical Journal of Chinese People's Liberation Army 2001;0(12):-
Objective To construct the inducible vector carrying green fluorescence protein(GFP). Methods We constructed an inducible vector pMD-GFP, including GFP cDNA, which allowed controlled expression of protein upon addition of 100 ?mol/L Zinc as an external inducer. The whole length of GFP cDNA were transfected into human hepatocellular cancer cells HCC-9204 by the method of lipofectin transfection. The expression of GFP was observed under fluorescence microscopy. Results The inducible vector carrying green fluorescence protein was successfully constructed. The observation under fluorescence microscopy showed that green fluorescence was spread in entire HCC-9204 cells transfected with GFP gene. Conclusion This new kind of the inducible vector could serve as a new tool and method for observing the growth and metastasis of neoplasm.